|
||||||||||||||||||
|
||||||||||||||||||
| HUM-MOLGEN -> biomedical companies | search | registration | modification | ||||||||||||||||||
registry of biomedical companies |
||||||||||||||||||
| December 22, 2024 |
promoting the transfer of scientific know-how between industry and academia |
|||||||||||||||||
Recommended Products: Aliskiren HemifumarateCas No. 173334-58-2 4-[(2R)-2-(Chloromethyl)-3-methylbutyl]-1-methoxy-2-(3-methoxypropoxy)benzene Cas No.324763-39-5 5(S)-[1(S)-Azido-3(S)-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentyl]-3(S)-isopropyldihydrofuran-2-one Cas No.324763-46-4 (2S,4E)-5-Chloro-N,N-dimethyl-2-(1-methylethyl)-4-pentenamide Cas No.324519-68-8 tert-butyl (3S,5S,6S,8S)-8-(3-amino-2,2-dimethyl-3-oxopropylcarbamoyl)-6-hydroxy-3-(4-methoxy-3-(3-methoxypropoxy)benzyl)-2,9-dimethyldecan-5-ylcarbamate Cas No.173338-07-3 (2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-2-isopropyl-7-(4-methoxy-3-(3-methoxypropoxy)benzyl)-8-methylnonanamide (2S,4S,5S,7S)-7-(3-(3-Methoxypropoxy)-4-Methoxybenzyl)-5-Azido-N-(2-Carbamoyl-2-Methylpropyl)-4-Hydroxy-2-Isopropyl-8-Methylnonanamide Cas No.324763-47-5 3-Amino-2,2-dimethylpropionamide Cas No.324763-51-1 Argatroban Cas No.141396-28-3 (2R,4R)-1-[NG-nitro-N2-(3-methyl-8-quinolinesulfonyl)-L-arginyl]-4-methyl-2-piperidinecarboxylic acid Cas No.74874-10-5 3-Methyl-8-quinolinesulphonyl chloride Cas No.74863-82-4 (2R,4R)-4-Methylpipecolinic acid Cas No.74892-81-2 Ethyl (2R,4R)-4-methyl-2-piperidinecarboxylate Cas No.74892-82-3 Ethyl (2R,4R)-1-(Nitroglycerine-nitro-L-arginyl)-4-methyl-piperidinecarboxylate hydrochloride Cas No.74874-08-1 Entecavir Monohydrate Cas No. 209216-23-9 2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one Cas No. 142217-81-0 6-(Benzyloxy)-9-((1S,3R,3S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-amine Cas No.142217-80-9 (1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol Cas No.142217-77-4 2-Amino-6-(phenylmethoxy)-9H-purine Cas No.19916-73-5 Pemetrexed Disodium Cas No.357166-30-4 Cas No.357166-29-1 4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pymol[2,3-d]pyrimodin-5-yl)ethyl] benzoic acid Cas No.137281-39-1 4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic acid methyl ester Cas No. 155405-80-4 N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid Cas No.126016-79-3 N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]L-glutamic acid, 1, 5-diethylester,4-methylbenzenesulfonate (1:1) Cas No. 165049-28-5 Posaconazole Cas No. 171228-49-2 (5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl ester Cas No.149809-43-8 1-(4-Aminophenyl)-4-(4-hydroxyphenyl)piperazine Cas No.74853-08-0 2-[(1S,2S)-1-Ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1,2,4-triazol-3-one Cas No.184177-83-1 Dronedarone HCl Cas No. 141625-93-6 N-(3-Chloropropyl)dibutylamine Cas No.36421-15-5 N-Butyl-N-(3-chloropropyl)-1-butanamine hydrochloride Cas No.115555-77-6 2-Butyl-3-(4-hydroxybenzoyl)-5-nitrobenzofuran Cas No.141645-16-1 Methanone, (5-amino-2-butyl-3-benzofuranyl)[4-[3-(dibutylamino)propoxy]phenyl]-, oxalate Cas No. 500791-70-8 Dronedarone Cas No.141626-36-0 Sitagliptin Phosphate Cas No. 654671-77-9 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[4,3-a]pyrazine hydrochloride Cas No.762240-92-6 Boc-(R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid Cas No.486460-00-8 duloxetine hydrochloride Cas No.136434-34-9 (S)-(-)-3-(N-Methylamino)-1-(2-thienyl)-1-propanol Cas No.116539-55-0 Cladribine Cas No. 4291-63-8 Fondaparinux Sodium Cas No. 114870-03-0 Alvimopan Cas No. 156053-89-3 Altrenogest Cas No.850-52-2 7-Methoxyestradiol Cas No.362-07-2 Dienogest Cas No.65928-58-7 Nestorone Cas No.7759-35-5 Melengestrol Cas No.2919-66-6 Medrogestone Cas No.977-79-7 Deflazacort Cas No.14484-47-0 Bromopride Cas No.4093-35-0 Selected Categories:
Last update of this entry: September 13, 2016
|
||||||||||||||||||
|
||||||||||||||||||
|
Generated by companies 4.0 by Kai Garlipp |
||||||||||||||||||